# A. Keith Stewart

Source: https://onco.cc/people/keith-stewart/  
OnCo record `keith-stewart` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Keith Stewart is a myeloma researcher who leads Canada's largest cancer centre.

## Summary

A. Keith Stewart is Director of the Princess Margaret Cancer Centre and Vice President, Cancer, at University Health Network, having previously worked at the Mayo Clinic Comprehensive Cancer Center in Arizona. He is a multiple myeloma researcher known for leading the ASPIRE trial of carfilzomib in relapsed disease and for myeloma genomics studies. His selected paper reports the combination of carfilzomib, lenalidomide and dexamethasone for relapsed multiple myeloma. He now combines academic leadership of Canada's largest cancer centre with continued work in myeloma and cancer genomics.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director, Princess Margaret Cancer Centre; Vice President, Cancer, University Health Network
- Specialisms: Multiple myeloma; Cancer genomics; Academic leadership

## Sources

- Princess Margaret: https://www.uhn.ca/PrincessMargaret
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Stewart%20AK%5BAuthor%5D

## Connected records

- cancers: [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- drugs: [Carfilzomib](https://onco.cc/drugs/carfilzomib/), [Lenalidomide](https://onco.cc/drugs/lenalidomide/)
- institutions: [Mayo Clinic Comprehensive Cancer Center in Arizona](https://onco.cc/institutions/mayo-clinic-arizona/), [Princess Margaret Cancer Centre](https://onco.cc/institutions/princess-margaret/)

---
JSON: https://onco.cc/api/v1/entities/keith-stewart.json